PMA supplement
P890064 S001: VIRATYPE HUMAN PAPILLOMAVIRUS DNA TYPING KIT
FDA PMA supplement · Normal 180 Day Track · Qiagen Gaithersburg, Inc.
Key facts
| Original PMA | P890064 |
|---|---|
| Supplement number | S001 |
| Supplement type | Normal 180 Day Track |
| Reason for the supplement | Location Change - Manufacturer/Sterilizer/Packager/Supplier |
| Trade name | VIRATYPE HUMAN PAPILLOMAVIRUS DNA TYPING KIT |
| Generic name | KIT, DNA DETECTION, HUMAN PAPILLOMAVIRUS |
| Applicant | Qiagen Gaithersburg, Inc. |
| Product code | MAQ |
| Received date | Oct 18, 1991 |
| Decision date | May 17, 1993 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: